Skip to main content

Concurrent Investment Advisors, LLC

Position in RCKT — Rocket Pharmaceuticals, Inc.

CIK 2001015 Tampa, FL

Position in RCKT

as of Mar 31, 2026 · filed Apr 21, 2026
Position Value
$252,836
+$13,820 QoQ
Shares Held
70,625
+3.7% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RCKT Over Time

Shares Held

Position Value (USD)

Derivatives in RCKT

reported options exposure · as of Jun 30, 2025
CallValue
$6,125
CallShares
2,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Concurrent Investment Advisors, LLC holds $31,084,354 across 38 Biotechnology names. RCKT ranks #22 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RCKT

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $252,836 70,625
2025-12-31 $239,016 68,096
2025-09-30 $248,072 76,096
2025-06-30 $6,125 2,500
2025-06-30 $138,684 56,606